Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib

BACKGROUND: Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pantaleo, Maria Abbondanza, Mandrioli, Anna, Saponara, Maristella, Nannini, Margherita, Erente, Giovanna, Lolli, Cristian, Biasco, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407789/
https://ncbi.nlm.nih.gov/pubmed/22687270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-231
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados